1. A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom
- Author
-
Thierry Rigoine de Fougerolles, Joan Puig‐Barbera, George Kassianos, Philippe Vanhems, Jorg Schelling, Pascal Crepey, Raul Ortiz Lejarazu, Filippo Ansaldi, Markus Fruhwein, Cristina Galli, Anne Mosnier, Elena Pariani, Anvar Rasuli, Olivier Vitoux, John Watkins, Thomas Weinke, Hélène Bricout, Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Ludwig-Maximilians-Universität München (LMU), École des Hautes Études en Santé Publique [EHESP] (EHESP), Université de Rennes (UR), Universidad de Valladolid [Valladolid] (UVa), Università degli studi di Genova = University of Genoa (UniGe), Università degli Studi di Milano = University of Milan (UNIMI), Réseau des Groupes Régionaux d'Observation de la Grippe (GROG), Coordination nationale, Sanofi Pasteur [Lyon, France], Cardiff University, and Klinikum Ernst von Bergmann [Potsdam, Germany] (KEVB)
- Subjects
Pulmonary and Respiratory Medicine ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,surveillance ,Public Health, Environmental and Occupational Health ,COVID-19 ,United Kingdom ,burden ,Europe ,Infectious Diseases ,Italy ,Spain ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Germany ,Influenza, Human ,Humans ,epidemiology ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,France ,Seasons ,influenza ,Pandemics - Abstract
Background\ud In response to the coronavirus disease (COVID-19) outbreak that unfolded across Europe in 2020, the World Health Organisation (WHO) called for repurposing existing influenza surveillance systems to monitor COVID-19. This analysis aimed to compare descriptively the extent to which influenza surveillance systems were adapted and enhanced and how COVID-19 surveillance could ultimately benefit or disrupt routine influenza surveillance.\ud \ud Methods\ud We used a previously developed framework in France, Germany, Italy, Spain and the United Kingdom to describe COVID-19 surveillance and its impact on influenza surveillance. The framework divides surveillance systems into seven subsystems and 20 comparable outcomes of interest and uses five evaluation criteria based on WHO guidance. Information on influenza and COVID-19 surveillance systems were collected from publicly available resources shared by European and national public health agencies.\ud \ud Results\ud Overall, non-medically attended, virological, primary care and mortality surveillance were adapted in most countries to monitor COVID-19, although community, outbreak and hospital surveillance were reinforced in all countries. Data granularity improved, with more detailed demographic and medical information recorded. A shift to systematic notification for cases and deaths enhanced both geographic and population representativeness, although the sampling strategy benefited from the roll out of widespread molecular testing. Data communication was greatly enhanced, contributing to improved public awareness.\ud \ud Conclusions\ud Well-established influenza surveillance systems are a key component of pandemic preparedness, and their upgrade allowed European countries to respond to the COVID-19 pandemic. However, uncertainties remain on how both influenza and COVID-19 surveillance can be jointly and durably implemented.
- Published
- 2021
- Full Text
- View/download PDF